Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1922 1
1947 1
1949 1
1971 1
1972 2
1973 1
1975 1
1977 1
1981 1
1983 1
1984 1
1987 2
1988 1
1999 2
2001 1
2002 2
2004 2
2005 1
2007 1
2008 1
2009 4
2010 5
2011 5
2012 7
2013 8
2014 3
2015 8
2016 10
2017 9
2018 6
2019 5
2020 11
2021 13
2022 9
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O'Riordan WD, Cochat P, Deschênes G, Shasha-Lavsky H, Saland JM, Van't Hoff WG, Fuster DG, Magen D, Moochhala SH, Schalk G, Simkova E, Groothoff JW, Sas DJ, Meliambro KA, Lu J, Sweetser MT, Garg PP, Vaishnaw AK, Gansner JM, McGregor TL, Lieske JC; ILLUMINATE-A Collaborators. Garrelfs SF, et al. Among authors: mcgregor tl. N Engl J Med. 2021 Apr 1;384(13):1216-1226. doi: 10.1056/NEJMoa2021712. N Engl J Med. 2021. PMID: 33789010 Clinical Trial.
Phenotype risk scores identify patients with unrecognized Mendelian disease patterns.
Bastarache L, Hughey JJ, Hebbring S, Marlo J, Zhao W, Ho WT, Van Driest SL, McGregor TL, Mosley JD, Wells QS, Temple M, Ramirez AH, Carroll R, Osterman T, Edwards T, Ruderfer D, Velez Edwards DR, Hamid R, Cogan J, Glazer A, Wei WQ, Feng Q, Brilliant M, Zhao ZJ, Cox NJ, Roden DM, Denny JC. Bastarache L, et al. Among authors: mcgregor tl. Science. 2018 Mar 16;359(6381):1233-1239. doi: 10.1126/science.aal4043. Science. 2018. PMID: 29590070 Free PMC article.
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
Michael M, Groothoff JW, Shasha-Lavsky H, Lieske JC, Frishberg Y, Simkova E, Sellier-Leclerc AL, Devresse A, Guebre-Egziabher F, Bakkaloglu SA, Mourani C, Saqan R, Singer R, Willey R, Habtemariam B, Gansner JM, Bhan I, McGregor T, Magen D. Michael M, et al. Among authors: mcgregor t. Am J Kidney Dis. 2023 Feb;81(2):145-155.e1. doi: 10.1053/j.ajkd.2022.05.012. Epub 2022 Jul 14. Am J Kidney Dis. 2023. PMID: 35843439 Free article. Clinical Trial.
Reply by Authors.
Pruthi DK, Miller G, Ankerst DP, Neumair M, Capitanio U, Correa AF, Lane BR, Roussel E, McGregor TB, Derweesh IH, Cordeiro M, Pierorazio PM, Calvo C, Bi H, Noyes SL, Meagher M, Kutikov A, Uzzo RG, Van Poppel H, Larcher A, Montorsi F, Kattan MW, Kaushik D, Liss MA. Pruthi DK, et al. Among authors: mcgregor tb. J Urol. 2023 Nov;210(5):761-762. doi: 10.1097/JU.0000000000003650.04. Epub 2023 Nov 1. J Urol. 2023. PMID: 37811759 No abstract available.
PharmGKB summary: very important pharmacogene information for MT-RNR1.
Barbarino JM, McGregor TL, Altman RB, Klein TE. Barbarino JM, et al. Among authors: mcgregor tl. Pharmacogenet Genomics. 2016 Dec;26(12):558-567. doi: 10.1097/FPC.0000000000000247. Pharmacogenet Genomics. 2016. PMID: 27654872 Free PMC article. Review. No abstract available.
Crowdfunding in urology: Canadian perspective.
Di Carlo A, Leveridge M, McGregor TB. Di Carlo A, et al. Among authors: mcgregor tb. Can Urol Assoc J. 2021 Mar;15(3):E139-E143. doi: 10.5489/cuaj.6572. Can Urol Assoc J. 2021. PMID: 32807287 Free PMC article.
Phimosis--a diagnostic dilemma?
McGregor TB, Pike JG, Leonard MP. McGregor TB, et al. Can J Urol. 2005 Apr;12(2):2598-602. Can J Urol. 2005. PMID: 15877942
Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children.
Sas DJ, Magen D, Hayes W, Shasha-Lavsky H, Michael M, Schulte I, Sellier-Leclerc AL, Lu J, Seddighzadeh A, Habtemariam B, McGregor TL, Fujita KP, Frishberg Y; ILLUMINATE-B Workgroup. Sas DJ, et al. Among authors: mcgregor tl. Genet Med. 2022 Mar;24(3):654-662. doi: 10.1016/j.gim.2021.10.024. Epub 2021 Dec 8. Genet Med. 2022. PMID: 34906487 Free article. Clinical Trial.
Diabetes, Obesity, and Pathological Upstaging in Renal Cell Carcinoma: Results From a Large Multi-institutional Consortium.
Pruthi DK, Miller G, Ankerst DP, Neumair M, Capitanio U, Correa AF, Lane BR, Roussel E, McGregor TB, Derweesh IH, Cordeiro M, Pierorazio PM, Calvo C, Bi H, Noyes SL, Meagher M, Kutikov A, Uzzo RG, Van Poppel H, Larcher A, Montorsi F, Kattan MW, Kaushik D, Liss MA. Pruthi DK, et al. Among authors: mcgregor tb. J Urol. 2023 Nov;210(5):750-762. doi: 10.1097/JU.0000000000003650. Epub 2023 Aug 14. J Urol. 2023. PMID: 37579345
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial.
Hayes W, Sas DJ, Magen D, Shasha-Lavsky H, Michael M, Sellier-Leclerc AL, Hogan J, Ngo T, Sweetser MT, Gansner JM, McGregor TL, Frishberg Y. Hayes W, et al. Among authors: mcgregor tl. Pediatr Nephrol. 2023 Apr;38(4):1075-1086. doi: 10.1007/s00467-022-05684-1. Epub 2022 Aug 1. Pediatr Nephrol. 2023. PMID: 35913563 Free PMC article. Clinical Trial.
119 results